
Vc-MMAD
CAS No. 1401963-17-4
Vc-MMAD( —— )
Catalog No. M33562 CAS No. 1401963-17-4
Vc-MMAD, a drug-linker conjugate for Antibody-Drug Conjugates (ADCs), combines the ADC linker Val-Cit (Valine-Citrulline) with the potent tubulin inhibitor MMAD.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 132 | Get Quote |
![]() ![]() |
5MG | 188 | Get Quote |
![]() ![]() |
10MG | 282 | Get Quote |
![]() ![]() |
25MG | 457 | Get Quote |
![]() ![]() |
50MG | 635 | Get Quote |
![]() ![]() |
100MG | 837 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameVc-MMAD
-
NoteResearch use only, not for human use.
-
Brief DescriptionVc-MMAD, a drug-linker conjugate for Antibody-Drug Conjugates (ADCs), combines the ADC linker Val-Cit (Valine-Citrulline) with the potent tubulin inhibitor MMAD.
-
DescriptionVc-MMAD consists the ADCs linker (Val-Cit) and potent tubulin inhibitor (MMAD). Vc-MMAD is a agent-linker conjugate for ADC.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAntibody Drug Conjugates (ADC)
-
TargetDrug-Linker Conjugates
-
RecptorDrug-Linker Conjugates for ADC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1401963-17-4
-
Formula Weight1369.71
-
Molecular FormulaC70H104N12O14S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 160 mg/mL (116.81 mM )
-
SMILESCCC(C)C(C(CC(=O)N1CCCC1C(OC)C(C)C(=O)NC(Cc1ccccc1)c1nccs1)OC)N(C)C(=O)C(NC(=O)C(C(C)C)N(C)C(=O)OCc1ccc(NC(=O)C(CCCNC(N)=O)NC(=O)C(NC(=O)CCCCCN2C(=O)C=CC2=O)C(C)C)cc1)C(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Antibody-drug conjugates Patent: WO 2013068874 A1
molnova catalog



related products
-
Val-Cit-PAB-MMAE
A drug-linker conjugate for Antibody-drug conjugates (ADCs) by using the anti-mitotic agent, monomethyl auristatin E (MMAE), linked via the cleavable peptide Val-Cit-PAB.
-
MAL-di-EG-Val-Cit-PA...
A drug-linker conjugate for antibody-drug conjugate by using the anti-mitotic agent, monomethyl auristatin E (MMAE), linked via the cleavable peptide SuO-Val-Cit-PAB.
-
Vc-MMAD
Vc-MMAD, a drug-linker conjugate for Antibody-Drug Conjugates (ADCs), combines the ADC linker Val-Cit (Valine-Citrulline) with the potent tubulin inhibitor MMAD.